Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with <i>PIK3CA</i> Mutations: The Phase Ib SOLTI-1507 IPATHER Trial
Year: 2025
Type: article
Language: en
Topic: HER2/EGFR in Cancer Research
Authors and affiliations:
raw_author_name: Mafalda Oliveira
raw_affiliation_strings: 1Medical Oncology Department, Vall d’Hebron University Hospital, and Breast Cancer Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
2SOLTI Cancer Research Group, Barcelona, Spain
Vall d'Hebron Hospital Universitari, Barcelona, Spain
raw_author_name: Eva Ciruelos
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
3Medical Oncology Department, University Hospital 12 De Octubre, Madrid, Spain
4Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain
Research Institute Hospital 12 de Octubre, Madrid, Madrid, Spain
raw_author_name: Guillermo Villacampa
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
Vall d'Hebron Institute of Oncology, Barcelona, Spain
raw_author_name: Serafín Morales
raw_affiliation_strings: 5Medical Oncology Department, Hospital Universitario Arnau de Vilanova, Lleida, Spain
Hospital Universitari Arnau de Vilanova, Lleida, Spain
raw_author_name: Javier Salvador Bofill
raw_affiliation_strings: 6Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain/Instituto de BioMedicina de Sevilla (IBIS), Seville, Spain
Hospital Universitario Virgen del Rocio, Seville, Spain
raw_author_name: Vanesa Quiroga
raw_affiliation_strings: 7Medical Oncology Department, Badalona-Applied Research Group in Oncology (B-ARGO Group), Catalan Institute of Oncology, Barcelona, Spain
Institut Català d'Oncologia, Badalona, Spain
raw_author_name: Joaquín Gavilá
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
8Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain
Fundación Instituto Valenciano de Oncología, Valencia, Spain
raw_author_name: Alexandra Cortegoso
raw_affiliation_strings: 9Medical Oncology Department, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
University of Santiago de Compostela, Spain
raw_author_name: Estela Vega
raw_affiliation_strings: 10Medical Oncology Department, Centro Integral Oncológico Clara Campal, Madrid, Spain
Hospital Universitario HM Madrid, Madrid, Spain
raw_author_name: Fernando Henao
raw_affiliation_strings: 11Medical Oncology Department, Hospital Virgen de Macarena, Sevilla, Spain
Hospital Universitario Virgen Macarena, Seville, Spain
raw_author_name: Sonia Servitja
raw_affiliation_strings: 12Medical Oncology Department, Hospital del Mar, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain
Hospital Del Mar, Barcelona, Spain
raw_author_name: Pablo Tolosa
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
3Medical Oncology Department, University Hospital 12 De Octubre, Madrid, Spain
4Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain
Research Institute Hospital 12 de Octubre, Madrid, Spain
raw_author_name: Samyukta Chillara
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
Solti, Barcelona, Spain
raw_author_name: Milana Bergamino
raw_affiliation_strings: 13Medical Oncology Department, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
Hospital Clinic de Barcelona, Barcelona, Spain
raw_author_name: Fernando Salvador
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
SOLTI Cancer Research Group, Barcelona, Spain
raw_author_name: Mariana Paes Dias
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
Solti, Barcelona, Spain
raw_author_name: Juan M. Ferrero-Cafiero
raw_affiliation_strings: 2SOLTI Cancer Research Group, Barcelona, Spain
Solti, Barcelona, Spain
raw_author_name: Xavier Gonzalez Farre
raw_affiliation_strings: 14Medical Oncology Department, Institut Oncològic Dr. Rosell, Barcelona, Spain
2SOLTI Cancer Research Group, Barcelona, Spain
Hospital General de Catalunya, Sant Cugat del Valles, Spain
raw_author_name: Tomás Pascual
raw_affiliation_strings: 13Medical Oncology Department, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
2SOLTI Cancer Research Group, Barcelona, Spain
Solti, Barcelona, Cataluña, Spain
raw_author_name: Cristina Saura
raw_affiliation_strings: 1Medical Oncology Department, Vall d’Hebron University Hospital, and Breast Cancer Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
2SOLTI Cancer Research Group, Barcelona, Spain
Vall d'Hebron Institute of Oncology, Barcelona, Spain